Exchange: NYSEMkt·Updated 07:48 PM EST

TGEN News

News
all
press releases
Insider Buying, FDA Buzz and AI Gold Rush: Six Stocks Investors Should Not Ignore
Ainos (NASDAQ:AIMD), NeOnc Technologies Holdings (NASDAQ:NTHI), enGene Therapeutics (NASDAQ:ENGN), CuriosityStream (NASDAQ:CURI), Tecogen (NYSEAMERICAN:TGEN) and Exascale Labs Holdings (NASDAQ:XLAB) are offering compelling narratives.
24-7 Market News
Insider Buying, FDA Buzz and AI Gold Rush: Six Stocks Investors Should Not Ignore
Ainos (NASDAQ:AIMD), NeOnc Technologies Holdings (NASDAQ:NTHI), enGene Therapeutics (NASDAQ:ENGN), CuriosityStream (NASDAQ:CURI), Tecogen (NYSEAMERICAN:TGEN) and Exascale Labs Holdings (NASDAQ:XLAB) are offering compelling narratives.
24-7 Market News
More News
The headline numbers for Tecogen (TGEN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Tecogen (TGEN) delivered earnings and revenue surprises of +28.57% and +22.26%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Aaon (AAON) delivered earnings and revenue surprises of +45.61% and +18.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Fortune Brands Innovations (FBIN) delivered earnings and revenue surprises of -4.00% and -0.54%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Tecogen (TGEN) delivered earnings and revenue surprises of +22.22% and -2.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Aaon (AAON) delivered earnings and revenue surprises of +32.69% and +21.81%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Fortune Brands Innovations (FBIN) delivered earnings and revenue surprises of +66.67% and -0.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lennox (LII) delivered earnings and revenue surprises of +1.18% and -1.12%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
The mean of analysts' price targets for Tecogen (TGEN) points to a 28% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks

Advertisement|Remove ads.